Evaluation of the safety and immunogenicity of pneumococcal seven-valent conjugate vaccine (Prevenar) administered in previously unvaccinated Spanish children aged 24 to 36 months.

Authors

J de Arístegui Fernández
B Cos Arregui
A Zurimendi Carril
M V. Alday Esteban
J Alzua Ruiz
E De la Fuente Jausoro
I Maturana San Pedro
M J. López Michelena
C Mourelo Carballo
M I. Quintanilla Sánchez
I Abad Therón
C O. Cimino
Mary A. Fletcher, Nova Southeastern UniversityFollow
A Pérez Domínguez

Publication Title

Vaccine

ISSN

0264-410X

Publication Date

3-1-2005

Volume

23

Issue

16

First Page

1917

Last Page

22

Disciplines

Medical Specialties | Medicine and Health Sciences | Osteopathic Medicine and Osteopathy

NSUWorks Citation

de Arístegui Fernández, J; Cos Arregui, B; Zurimendi Carril, A; Alday Esteban, M V.; Alzua Ruiz, J; De la Fuente Jausoro, E; Maturana San Pedro, I; López Michelena, M J.; Mourelo Carballo, C; Quintanilla Sánchez, M I.; Abad Therón, I; Cimino, C O.; Fletcher, Mary A.; and Pérez Domínguez, A, "Evaluation of the safety and immunogenicity of pneumococcal seven-valent conjugate vaccine (Prevenar) administered in previously unvaccinated Spanish children aged 24 to 36 months." (2005). Faculty Articles. 855.
https://nsuworks.nova.edu/hpd_com_faculty_articles/855